Clinical Trial Update: Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a completed Phase 1/2 clinical trial evaluating radiation therapy with or without the anti-angiogenic agent SU5416 (semaxanib) in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• SU5416 (semaxanib)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Sarcoma | Phase 1, Phase 2 | Status: COMPLETED